Evaluating the Effects of Omeprazole on the Pharmacokinetics of XS004 (Dasatinib) Tablets in Healthy Adult Subjects Under Fasting Conditions
Clinical trial NCT05433896 · COMPLETED
Trial details
- NCT number
- NCT05433896
- Sponsor
- Xspray Pharma AB
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-01
- Primary completion
- 2020-12-19
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.